Year archive

Jamjoom Pharmaceuticals Factory Co. — 2024 filings

All 22 regulatory filings released by Jamjoom Pharmaceuticals Factory Co. (4015) in 2024, sourced directly from the official regulator.

22 Filings

2024 Period

2024 filings (22)

Filing	Released	Lang
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2024-09-30 ( Nine Months ) Interim / Quarterly Report	2024-10-27	English
Jamjoom Pharmaceuticals Factory Co. announces its intention to release its 3rd quarter financial results for the period ended 30 September 2024 on Sunday, October 27, 2024, before the trading session Report Publication Announcement	2024-10-10	English
Jamjoom Pharmaceuticals Factory Co. announces the board of director’s recommendation to distribute cash dividends for First half of 2024 (Six months) Notice of Dividend Amount	2024-08-06	English
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2024-06-30 ( Six Months ) Interim / Quarterly Report	2024-08-06	English
Jamjoom Pharmaceuticals Factory Co. announces its intention to release its second quarter financial results for the period ended 30 June 2024 on Tuesday, August 6, 2024, before the trading session beg Earnings Release	2024-07-18	English
Jamjoom Pharmaceuticals Factory Company announces providing a corporate guarantee to its joint venture in Algeria Capital/Financing Update	2024-07-08	English
Jamjoom Pharmaceuticals Factory Co. Announces the Results of the Ordinary General Assembly Meeting, ( First Meeting ) Declaration of Voting Results & Voting Rights Announcements	2024-07-07	English
Jamjoom Pharmaceuticals Factory Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting) AGM Information	2024-06-13	English
Jamjoom Pharmaceuticals Factory Co. Announces the Results of the Extraordinary General Assembly Meeting ( First Meeting ) Declaration of Voting Results & Voting Rights Announcements	2024-06-05	English
Jamjoom Pharmaceuticals Factory Co. Board invites its shareholders to attend the Extraordinary General Assembly Meeting the ( First Meeting ) AGM Information	2024-05-14	English
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months ) Interim / Quarterly Report	2024-05-09	English
Jamjoom Pharmaceuticals Factory Co. announces the board of director’s recommendation to distribute cash dividends for the second half of the year 2023. Notice of Dividend Amount	2024-04-04	English
Jamjoom Pharmaceuticals Factory Co. announces its Annual Financial results for the period ending on 2023-12-31 Earnings Release	2024-03-25	English
Jamjoom Pharmaceuticals Factory Co. announces its intention to release its annual financial results for the year ended 31 December 2023 on Monday, March 25, 2024, before the trading session begins on Report Publication Announcement	2024-03-19	English
Correction announcement from Jamjoom Pharmaceuticals Factory Co. in regards to its Announcement on the Results of the Extraordinary General Assembly Meeting (First Meeting) Declaration of Voting Results & Voting Rights Announcements	2024-03-14	English
Jamjoom Pharmaceuticals Factory Co. Announces the Results of the Extraordinary General Assembly Meeting, ( First Meeting ) Declaration of Voting Results & Voting Rights Announcements	2024-03-13	English
Jamjoom Pharmaceuticals Factory Co. Board invites its shareholders to attend the Extraordinary General Assembly Meeting the ( First Meeting ) Proxy Solicitation & Information Statement	2024-02-20	English
Addendum Announcement from Jamjoom Pharmaceuticals Factory Company regarding Contract Sign Off with Local Content & Government Procurement Authority Regulatory Filings	2024-02-01	English
Jamjoom Pharmaceuticals Factory Co. Announces Contract Sign Off with Local Content & Government Procurement Authority Regulatory Filings	2024-01-30	English
Jamjoom Pharmaceuticals Factory Company announces obtaining approval from Saudi Food and Drug Authority (SFDA) to register its new Sterile Facility (ophthalmic products) in Jeddah Regulatory Filings	2024-01-28	English
Jamjoom Pharmaceuticals Factory Company announces providing a corporate guarantee to its Joint Venture in Algeria Capital/Financing Update	2024-01-21	English
Jamjoom Pharmaceuticals Factory Co. Announces that it will be presenting at the 42nd JP Morgan Healthcare Conference 2024 Investor Presentation	2024-01-10	English